T6S1315 |
Oroxylin A
|
480-11-5
|
99.67%
|
|
1. Oroxylin A (Baicalein 6-methyl ether) has various anti-tumor effects including apoptosis, cell cycle arrest, drug-resistant reversion. 2. Oroxylin A possesses...
|
T2488 |
BAY 87-2243
|
1227158-85-1
|
99.65%
|
|
BAY 87-2243 is a potent and selective inhibitor of hypoxia-inducible factor-1 (HIF-1).
|
T15219 |
Enarodustat
|
1262132-81-9
|
99.61%
|
|
Enarodustat (JTZ-951) is an orally active factor inhibitor of prolyl hydroxylase (EC50: 0.22 μM) and has the potential for renal anemia treatment.
|
T5S2347 |
Deoxyshikonin
|
43043-74-9
|
99.58%
|
|
1. Deoxyshikonin (Arnebin 7) may be a new drug candidate for wound healing and treatment of lymphatic diseases. 2. Deoxyshikonin enhances the ability of human de...
|
T0153 |
Oltipraz
|
64224-21-1
|
99.56%
|
|
Oltipraz (RP 35972) is a synthetic dithiolethione with potential chemopreventive and anti-angiogenic properties. Oltipraz induces phase II detoxification enzymes...
|
T2792 |
Glucosamine sulfate
|
29031-19-4
|
99.49%
|
|
Glucosamine sulfate (D-Glucosaminesulfate) was extracted from synthetic product;Store the product in sealed, cool and dry condition.
|
T5392 |
TP0463518
|
1558021-37-6
|
99.43%
|
|
TP-0463518 is a highly potent HIF prolyl hydroxylase (PHD) inhibitor (IC50s: 13 nM and 18 nM for human and rat PHD2, respectively).
|
T2805 |
Chlorogenic Acid
|
327-97-9
|
99.43%
|
|
Chlorogenic Acid (NSC-407296) is a naturally occurring phenolic acid which is a carcinogenic inhibitor. It has also been shown to prevent paraquat-induced oxidat...
|
T7848 |
PT-2385
|
1672665-49-4
|
99.39%
|
|
PT-2385 is a selective HIF-2α inhibitor (Kd<50 nM).
|
T6S0071 |
Fraxinellone
|
28808-62-0
|
99.35%
|
|
1. Fraxinellone significantly reduced weight loss and diarrhea in mice and alleviated the macroscopic and microscopic signs of the disease. 2. Fraxinellone exhib...
|
T11561 |
HIF-2α-IN-2
|
1672666-82-8
|
99.33%
|
|
HIF-2α-IN-2 is a hypoxia-inducible factor (HIF-2α) inhibitor (IC50: 16 nM in scintillation proximity assay).
|
T13289 |
EHP-101
|
1818428-24-8
|
99.22%
|
|
EHP-101 (VCE-004.8) is a specific dual agonist of PPARγ and CB2 receptor with potent anti-inflammatory activity. EHP-101 attenuates adipogenesis and prevents die...
|
T3169 |
KC7F2
|
927822-86-4
|
99.11%
|
|
KC7F2 is a potent HIF-1 pathway inhibitor with potential anti-cancer activity.
|
T3494 |
LW6
|
934593-90-5
|
99.10%
|
|
LW6 (HIF-1α inhibitor) is a novel HIF-1 inhibitor.
|
T13050 |
SYP-5
|
1384268-04-5
|
99.1%
|
|
SYP-5 is a novel inhibitor of HIF-1, suppresses tumor cells invasion and angiogenesis.
|
T1613 |
Hydralazine hydrochloride
|
304-20-1
|
99.1%
|
|
Hydralazine hydrochloride (Apresoline) is the hydrochloride salt of hydralazine, a phthalazine derivative with antihypertensive and potential antineoplastic acti...
|
T17105 |
TM6089
|
863421-32-3
|
99.07%
|
|
TM6089 is an inhibitor of Prolyl Hydroxylase that stimulates HIF activity without iron chelation, induces angiogenesis, and protects organ against ischemia.
|
T12675L |
PT2399
|
1672662-14-4
|
99.07%
|
|
PT2399 shows effective antitumor activity in vivo. PT2399 is an effective and selective HIF-2α antagonist, which directly binds to the HIF-2α PAS B domain (IC50:...
|
T2941 |
Glucosamine hydrochloride
|
66-84-2
|
99.07%
|
|
Glucosamine hydrochloride (Chitosamine hydrochloride) is commonly used as a treatment for osteoarthritis, although its acceptance as a medical therapy varies.
|
T7880 |
IOX4
|
1154097-71-8
|
98.87%
|
|
IOX4 is a potent PHD2 inhibitor (IC50 = 1.6 nM)
|